ChromaDex Corp.·4

Mar 17, 6:41 PM ET

BLOCK STEPHEN A 4

4 · ChromaDex Corp. · Filed Mar 17, 2021

Insider Transaction Report

Form 4
Period: 2021-03-15
Transactions
  • Exercise/Conversion

    Common Stock

    2021-03-15$1.92/sh+32,500$62,40049,167 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2021-03-1532,5000 total
    Exercise: $1.92From: 2012-09-28Exp: 2022-08-27Common Stock (32,500 underlying)
  • Exercise/Conversion

    Common Stock

    2021-03-16$2.60/sh+20,000$52,10036,667 total
  • Sale

    Common Stock

    2021-03-16$13.17/sh20,000$263,40016,667 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2021-03-1620,0000 total
    Exercise: $2.60From: 2017-11-16Exp: 2026-11-15Common Stock (20,000 underlying)
  • Sale

    Common Stock

    2021-03-15$11.15/sh32,500$362,37516,667 total
Footnotes (4)
  • [F1]The weighted average sale price for the transaction reported was $11.15, and the range of prices were between $11.10 and $11.25. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F2]The weighted average sale price for the transaction reported was $13.17, and the range of prices were between $13.10 and $13.34. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F3]The Options were granted on August 28, 2012 and vested 1/12th monthly from the grant date.
  • [F4]The options were granted on November 16, 2016 and 100% vested on November 16, 2017.

Documents

1 file
  • 4
    form4-03172021_030350.xmlPrimary